Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10- and IL-5-secreting T cells

Allergy. 2020 Feb;75(2):450-453. doi: 10.1111/all.13996. Epub 2019 Aug 29.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Allergens / immunology
  • Desensitization, Immunologic / methods*
  • Double-Blind Method
  • Epitopes, B-Lymphocyte / immunology*
  • Female
  • Humans
  • Interleukin-10 / metabolism*
  • Interleukin-5 / metabolism*
  • Male
  • Middle Aged
  • Plant Extracts / adverse effects
  • Plant Extracts / immunology
  • Poaceae / chemistry
  • Poaceae / immunology
  • Pollen / adverse effects
  • Pollen / immunology
  • Prospective Studies
  • Rhinitis, Allergic, Seasonal / etiology
  • Rhinitis, Allergic, Seasonal / therapy*
  • T-Lymphocytes / immunology*
  • Treatment Outcome
  • Vaccination / methods*
  • Vaccines / immunology*
  • Young Adult

Substances

  • Allergens
  • Epitopes, B-Lymphocyte
  • IL10 protein, human
  • IL5 protein, human
  • Interleukin-5
  • Plant Extracts
  • Vaccines
  • Interleukin-10